SCHEMBL29660410

SCHEMBL29660410

COc1ccc2c(c1Br)CCC2=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.67
ALDH1A1 P00352 5/20 0.67
HPGD P15428 2/20 0.67
GLA P06280 1/20 0.53
GAA P10253 1/20 0.53
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
USP2 O75604 2/20 0.43
S100A4 P26447 1/20 0.43
TUBB4A P04350 2/20 0.42
TUBB P07437 2/20 0.42
TUBA3C P0DPH7 2/20 0.42
TUBA1B P68363 2/20 0.42
TUBA4A P68366 2/20 0.42
TUBB4B P68371 2/20 0.42
TUBB3 Q13509 2/20 0.42
TUBB2A Q13885 2/20 0.42
TUBB8 Q3ZCM7 2/20 0.42
TUBA3E Q6PEY2 2/20 0.42
TUBA1A Q71U36 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3987174 1.00 KDM4E (0.67) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL3994779 0.90 KDM4E (0.54) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL30558421 0.90 KDM4E (0.54) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL21715395 0.90 ALDH1A1 (0.54) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL388362 0.80 ALDH1A1 (0.69) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL354324 0.80 KDM4E (1.00) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL23857698 0.79 KDM4E (0.67) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL3995103 0.79 KDM4E (0.67) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL6958079 0.79 KDM4E (0.67) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL5612688 0.79 KDM4E (0.67) KDM4EALDH1A1HPGDGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126855-A1 COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION F. Hoffmann-La Roche AG (CH) 2023-02-08 EP disclosed
CN-113195492-B Novel compound with three-fused ring structure, preparation method and application thereof 信达生物制药(苏州)有限公司 2022-07-08 CN disclosed